Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Bone Marrow Transplantation
100%
Relapsed Lymphoma
100%
High-dose Cytarabine
100%
Marrow Transplantation
100%
Low-dose Cisplatin
100%
Disease-free Survival
50%
Chemotherapy
25%
Combination Chemotherapy
25%
Doxorubicin
25%
Treatment-related Mortality
25%
Chemotherapy Regimen
25%
Myelosuppression
25%
Cisplatin
25%
Partial Response
25%
Objective Response
25%
Relapsed Patients
25%
Lactate Dehydrogenase
25%
Continuous Infusion
25%
Complete Response
25%
Histology
25%
Previous Chemotherapy
25%
Newly Diagnosed
25%
One Percent
25%
Salvage Therapy
25%
Two-dose
25%
Lymphoma Patients
25%
Primary Therapy
25%
Bulky Disease
25%
Cytarabine
25%
Long-term Prognosis
25%
Elevated Lactate
25%
B Symptoms
25%
High-grade non-Hodgkin Lymphoma
25%
Diffuse Large Cell
25%
High Tumor Burden
25%
Medicine and Dentistry
Cisplatin
100%
Non-Hodgkin Lymphoma
100%
Drug Megadose
100%
Cytarabine
100%
Bone Marrow Transplantation
100%
Dexamethasone
100%
Disease
50%
Disease Free Survival
50%
Neoplasm
25%
Doxorubicin
25%
Combination Chemotherapy
25%
Bone Marrow Suppression
25%
Chemotherapy Regimens
25%
Patient History of Chemotherapy
25%
Continuous Infusion
25%
Lactate Dehydrogenase
25%
Salvage Therapy
25%
Large Cell
25%
B Symptoms
25%
Pharmacology, Toxicology and Pharmaceutical Science
Cisplatin
100%
Nonhodgkin Lymphoma
100%
Cytarabine
100%
Dexamethasone
100%
Disease
50%
Chemotherapy
50%
Disease Free Survival
50%
Symptom
25%
Bone Marrow Suppression
25%
Neoplasm
25%
Patient History of Chemotherapy
25%
Doxorubicin
25%
Chemotherapy Regimens
25%
Lactate Dehydrogenase
25%
Neuroscience
Cisplatin
100%
Non-Hodgkin Lymphoma
100%
Dexamethasone
100%
Cytarabine
100%
Doxorubicin
25%
Chemotherapy Regimens
25%
Lactate Dehydrogenase
25%
Immunology and Microbiology
Drug Megadose
100%
Bone Marrow Transplantation
100%
Dexamethasone
100%
Disease Free Survival
50%
Tumor Volume
25%
Agricultural and Biological Sciences
Bone Marrow
100%
Dexamethasone
100%
Lactate Dehydrogenase
25%